Stay updated on Pembrolizumab Plus Lenvatinib Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FRjW4JZ_oguTg9MMHpUAPXsURKNE.uncropped.jpg&w=3840&q=75)
Latest updates to the Pembrolizumab Plus Lenvatinib Clinical Trial page
- ChecktodayChange DetectedThe website has removed the 'Last Update Posted (Estimated)' and now features a definitive 'Last Update Posted' section.SummaryDifference0.1%
- CheckyesterdayChange DetectedA new publication detailing the results of a phase 2 study on lenvatinib plus pembrolizumab for advanced ovarian cancer has been added, along with an estimated last update for July 2024, while previous last update entries from October 2023 have been removed.SummaryDifference2%
- Check2 days agoChange DetectedDifference0.1%
- Check3 days agoChange DetectedThe website has been updated to version 2.10.0, adding features to show more conditions and study numbers, and now includes information about 88 study locations.SummaryDifference0.3%
- Check5 days agoChange DetectedDifference0.2%
- Check7 days agoChange DetectedDifference0.3%
Stay in the know with updates to Pembrolizumab Plus Lenvatinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.